Expression of the GTPase-de®cient, activated mutant asubunit of the heterotrimeric G protein G12 (Ga 12 QL) leads to the neoplastic transformation of ®broblast cell lines. The mitogenic pathway regulated by Ga 12 QL includes an extensive signaling network involving several small GTPases and various kinases. In addition, Ga 12 QL has been shown to potentiate the serum-induced phospholipase-A 2 activity in NIH3T3 cells. In the present study, we demonstrate that cycloxygenase-2 (COX-2) pathway is involved in the mitogenic pathway activated by Ga 12 QL. Expression of Ga 12 QL and not Ga 13 QL, stimulates the serum-induced release of arachidonic acid in NIH3T3 cells. Furthermore, expression of Ga 12 QL or the stimulation of wild-type Ga 12 induces the expression of COX-2. Our results also indicate that the COX-2 inhibitor acutely disrupts the DNA-synthesis stimulated by Ga 12 QL in NIH3T3 cells. These studies, for the ®rst time, identify the crucial role of COX-2 in Ga 12 -mediated regulation of cell proliferation and suggest a role for prostaglandin-derived autocrine loop in Ga 12 -mediated signaling pathways.
Ga 12 , the a-subunit of the heterotrimeric G protein G12, is critically involved in the regulation of cell proliferation, dierentiation, and apoptosis (reviewed by Dhanasekaran and Dermott, 1996; Dhanasekaran et al., 1998) . In addition to its being identi®ed as the causative oncogene in soft tissue sarcomas (Chan et al., 1993) , the overexpression of wild-type Ga 12 or the expression of the GTPase-de®cient activated mutant of Ga 12 (Ga 12 Q229L or Ga 12 QL) has been shown to confer transforming ability to ®broblast cell lines (Chan et al., 1993; Xu et al., 1993 Xu et al., , 1994 Jiang et al., 1993; Vara Prasad et al., 1994; Voyno-Yasanetskaya et al., 1994) . Furthermore, the expression of the Ga 12 QL has been shown to stimulate DNA synthesis in several other cell-types such as 1321N1 astrocytoma cells (Aragay et al., 1995) . Studies from several laboratories including ours have shown that the proliferative pathway regulated by Ga 12 includes the Ras/Rac mediated activation of JNKs (Vara Prasad et al., 1995; Collins et al., 1996; Voyno-Yasenetskaya et al., 1996) , Rho-dependent activation of cytoskeletal changes (Buhl et al., 1995; Hooley et al., 1996; Needham and Rozengurt, 1998) , Rho-dependent activation of speci®c transcription factors (Fromm et al., 1997) , Rac/MEKK1-mediated activation of AP-1 complex (Collins et al., 1996) , and Ras/Rac/Rhodependent cell transformation (Zhang et al., 1996; Tolkacheva et al., 1997; Fromm et al., 1997) . In addition, it has been shown that serum-induced phospholipase A 2 (PLA 2 ) activity was potentiated by Ga 12 QL in NIH3T3 cells, suggesting a role for eicosanoids in Ga 12 QL signaling (Xu et al., 1993) . However, the role of eicosanoid pathway in Ga 12 -signaling has remained largely unknown.
In mammalian cells, the release of arachidonic acid from the membrane lipids is catalyzed by PLA 2 (Dennis, 1997) and the activity of PLA 2 is stringently regulated by hormones and growth factors (Dennis, 1997; Leslie, 1997) . Arachidonic acid is converted into other biologically active metabolites such as leukotrienes, lipoxins, prostaglandins and thromboxanes by dierent enzymes. The most important pathway is the sequential conversion of arachidonic acid into prostaglandin G 2 and prostaglandin H 2 by the enzyme prostaglandin endoperoxide synthase or cycloxygenase (Herschman, 1994; Dubois et al., 1998) . There are two distinct isoforms of cycloxygenase known as cycloxygenase-1 (COX-1) and cycloxygenase-2 (COX-2). Cycloxygenase 1 is ubiquitously expressed in all the cell types and is involved in cellular`housekeeping' functions of various tissues and organs (Herschman, 1994; Dubois et al., 1998; Vane et al., 1998) . In contrast, cycloxygenase-2 is an inducible enzyme whose induction and expression is dynamically regulated by growth factors, mitogens, tumor promoters, and physiological stress stimuli (Herschman, 1994; Dubois et al., 1998; Vane et al., 1998) . The persistent activation of COX-2 has been shown to be associated with oncogenesis as well as the invasive potential of tumor cells (Dubois et al., 1998; Vane et al., 1998; Tsujii et al., 1997) . It is signi®cant to note that prostaglandin H 2 , the ®nal product of COX-2, acts as the immediate precursor for other prostaglandins and thromboxanes that are involved in various autocrine as well as paracrine control mechanisms (Herschman, 1994) . Thus, it is likely that Ga 12 , which potentiates the release of arachidonic acid, is also involved in regulation of COX-2, thereby facilitating the synthesis of speci®c eicosanoids that can mediate Ga 12 -speci®c signaling events involved in cell proliferation and transformation. With this reasoning, we investigated whether COX-2 is involved in the mitogenic pathway regulated by Ga 12 . Our studies indicate, for the ®rst time, the critical role played by COX-2 in Ga 12 -mediated mitogenic pathway.
NIH3T3 cells transformed by Ga 12 showed an increased release of arachidonic acid release in response to 5% bovine serum (Figure 1a) con®rming the previously published observation of Xu et al. (1993) . Ga 12 is closely related to Ga 12 , the a-subunit of the heterotrimeric G protein G13. Both Ga 12 and Ga 13 show extensive sequence and functional similarities (Dhanasekaran and Dermott, 1996) . Hence, we examined whether the ability to modulate the eicosanoidsignaling pathway through the potentiation of serumstimulated PLA 2 was unique to Ga 12 . Ga 12 QLtransformed NIH3T3 cells along with Ga 13 QL-, RasV12-transformants and control NIH3T3 cells were labeled with 3 H-arachidonic acid and the release of arachidonic acid was monitored as an index of PLA 2 activity. In the absence of serum, none of the cells showed the release of arachidonic acid. Upon serum stimulation, all of the cell lines showed an increase in Figure 1 Arachidonic acid release by Ga 12 QL-NIH3T3 cells. The arachidonic acid release in NIH3T3 cells was determined following the procedures of Xu et al. (1993) . (a) Control (pcDNA3-NIH3T3) and Ga 12 QL-NIH3T3 were plated at 2610 4 cells per well in a 24-well plate and grown for 24 h at 378C in DMEM containing 5% bovine calf serum. The cells were labeled with 3 H-arachidonic acid (0.5 mCi/well) in 0.5 ml DMEM containing 10 mM HEPES (pH 7.4) and 0.2% BSA for 24 h. The cells were washed three times with PBS and placed in 0.5 ml of DMEM containing 10 mM HEPES (pH 7.4) and 0.2% fatty acid-free BSA in the presence or absence of 5% bovine serum. The cells were treated for 0, 2, 5, 10, 20 min with or without serum. The medium was removed, centrifuged (2000 g), and the arachidonic acid released into the medium was determined using a scintillation counter. Mean values+s.e.m. of triplicate samples of three (n=3) independent experiments are presented. (b) Control (pcDNA3-NIH3T3) and Ga 12 QL-NIH3T3, Ga 13 QL-NIH3T3, and RasV12-NIH3T3 cells were labeled with 3 H-arachidonic acid as described above. The labeled cells were washed three times with PBS and the cells were placed in 0.5 ml of DMEM containing 10 mM HEPES (pH 7.4) and 1% fatty acid-free BSA in the presence or absence of 5% bovine serum. After 10 min, the medium was removed, centrifuged (2000 g), and the arachidonic acid released into the medium was determined using a scintillation counter. The results are from four independent experiments (n=4) 6 cells per dish (100 mm) and grown for 24 h at 378 in DMEM containing 5% bovine calf serum. The cells were serum-starved in DMEM containing 10 mM HEPES (pH 7.4) and 0.2% BSA. Duplicate sets of the cells were stimulated with serum for 30 min and the lysates were prepared as previously described (Gebauer et al., 1999) . The lysates (50 mg) were resolved by SDS ± PAGE and electroblotted onto PVDF membranes (Millipore, Bedford, MA, USA) in 10 mM CAPS (3-cyclohexylamino-1-propane sulfonic acid) buer containing 10% methanol using a Mini-Protean apparatus (Bio-Rad, CA, USA), and probed with speci®c antibodies raised against the C-terminus of COX-2 (Oxford Biomedical Research, MI, USA). Lanes 1 ± 3 are from unstimulated cells whereas Lanes 4 ± 6 are from serumstimulated cells. Lanes 1 and 3: pcDNA3-NIH3T3; Lanes 2 and 5: Ga 12 WT-NIH3T3; and Lanes 3 and 6: Ga 12 QL-NIH3T3. (b) Ga 12 QL-dependent expression of COX-2. To demonstrate the inducible expression of COX-2, an NIH3T3 cell line that expresses Ga 12 QL under IPTG-inducible promoter was used (Vara Prasad et al., 1995) . Expression of Ga 12 QL was induced by the addition of 1 mM IPTG and the cells were harvested at dierent time points after IPTG-induction as indicated. Total RNA was prepared from the cells following the published procedures (Vara Prasad et al., 1994) . Twenty mg of RNA (for each time point) was resolved on a denaturing 1% agarose and 2.2 M formaldehyde gel and Northern analysis was performed using the respective cDNA probes. The cDNA probes were prepared as follows: The HindIII-XbaI fragment (1.2 kbp) of Ga 12 Q229L excised from Ga 12 QL-pcDNA3 and the XbaI-BamHI fragment (1.8 kbp) of COX-2 from the COX-2-pT7Blue vector were used as probes in Northern blot analyses. Murine COX-2 was cloned in the laboratory using RT ± PCR methods from the RNA prepared from NIH3T3 cells pretreated (6 h) with 100 nM PMA using the following primers: 5'-CTCTGCGATGCT-CTTCCGAG-3' and 5'-GACTTTTACAGCTCAGTTGAACG-3'. The ampli®ed 1827 bp PCR-product was sequenced and compared with the published sequences (Kujubu et al., 1991) to con®rm the identity of COX-2 cDNA. The COX-2 PCR-product was puri®ed and cloned into pT7Blue TA vector (Novagen, Madison, WI, USA) arachidonic acid release (Figure 1b) . However, Ga 12 QL-transformants showed a potent, twofold increase in the release of arachidonic acid over other cell types. In contrast, RasV12-and Ga 13 QL-transformants showed a response similar to those of the control NIH3T3 cells. These ®ndings clearly indicate that the potentiation of PLA 2 activity is speci®c to Ga 12 . These results also suggest that the increased PLA 2 response seen in Ga 12 -transformants is not due to transformed phenotype of these cells since RasV12-and Ga 13 QL-transformants fail to show this eect. Nevertheless, the observation that Ga 13 , which shows 60% identity to Ga 12 , fails to stimulate the release of arachidonic acid is more signi®cant and warrants an explanation. Since Ga 12 is more potent in stimulating cell growth than Ga 13 (Jiang et al., 1993; Vara Prasad et al., 1994) , it is more likely that the arachidonic acid driven eicosanoid-signaling pathway contributes signi®cantly to the robust growth promoting activity of Ga 12 . To determine whether Ga 12 stimulates such eicosanoid signaling pathway further downstream, we analysed the expression of COX-2, the key enzyme involved in the synthesis of eicosanoids, in Ga 12 QLtransformants.
The lysates from Ga 12 QL-transformed NIH3T3 cells and the control pcDNA3-NIH3T3 cells were subjected to immunoblot analysis using antibodies speci®c to COX-2. The results indicate that COX-2 is constitutively expressed in Ga 12 QL transformants (Figure 2a) . The overexpression of wild-type Ga 12 (Ga 12 WT) in NIH3T3 cells leads to the transformation of these cells presumably due to the stimulation of Ga 12 -coupled receptor by a`ligand' present in the serum (Chan et al., 1993) . Therefore, we examined whether such a stimulation of Ga 12 WT by serum activates the expression of COX-2. As indicated in Figure 2a , the expression of COX-2 is induced by serum-stimulated Ga 12 WT. These ®ndings are very similar to the observation that the stimulation of Ga 12 WT by à ligand' in the serum leads to the activation of cell proliferation (Chan et al., 1993) . Taken together, these ®ndings also suggested the close association between COX-2 expression and cell proliferation. Since COX-2 expression is transcriptionally regulated and rapidly inducible, a Northern blot analysis was carried out to further de®ne the Ga 12 -dependent expression of COX- Figure 3 Inhibition of Ga 12 QL-mediated DNA-synthesis by COX-2 inhibitor. Control (expressing pcDNA3 vector) and Ga 12 QL-transformed NIH3T3 cells were plated at 5610 4 cells per well in a 24-well plate and grown for 24 h at 378C in DMEM containing 5% FBS. The cells were washed and made quiescent by placing them in DMEM (+0.2% BSA) without serum for additional 24 h. The growth was reinitiated by the addition of 10% FBS with or without COX-2 inhibitor (10 mM in DMSO). Twelve hours later 1 mCi of thymidine (20 Ci/mmol) was added to each well and incubated for additional 4 h. Cells were washed in PBS and solubilized in 0.1% SDS. DNA was precipitated with 10% chilled TCA and the precipitate was collected on GFC ®lters. The counts in the precipitate were determined by scintillation counting. Mean values+s.e.m. of triplicate samples of three (n=3) independent experiments are presented Figure 4 A schematic model describing the mechanism by which Ga 12 QL-regulated COX-2 plays a role in cell proliferation. The mechanism by which Ga 12 potentiates PLA 2 -activity remains to be identi®ed. COX-2, cycloxygenase-2; PLA 2 , phospholipase A 2 ; AA, arachidonic acid 2. Previously, we established a cell line in which Ga 12 QL-expression was under the control of IPTGinducible promoter (Vara Prasad et al., 1995) . In these cells, the expression of Ga 12 QL can be induced by the addition of 1 mM IPTG into the cell culture medium. RNA from these cells was isolated at dierent time points following the induction of Ga 12 QL-expression by the addition of IPTG and was subjected to Northern blot analysis using a COX-2 probe. As shown in Figure 2b , induction of Ga 12 QL expression is accompanied by the accumulation of COX-2 mRNA. Together, these results clearly indicated that the stimulation of wild-type Ga 12 or the expression of constitutively activated Ga 12 QL results in the induction and expression of COX-2.
Recent studies have identi®ed the dominant role played by COX-2 in pathways regulating cell survival, cell proliferation, and oncogenesis. By co-stimulating the expression of COX-2 and potentiating the release of arachidonic acid (the substrate for COX-2), Ga 12 can prime the cells to produce more prostanoids. The prostaglandins or their metabolites in turn, can stimulate the cells to proliferate through an autocrine-signaling loop. In such an instance, the inhibition of COX-2 should disrupt the mitogenic pathway stimulated by Ga 12 QL. We tested this hypothesis by determining the eect of COX-2 inhibitors on Ga 12 -mediated cell proliferation. Since Ga 12 QL avidly stimulates DNA synthesis in NIH3T3 cells, the inhibitory eect of COX-2 inhibitors can be quanti®ed by monitoring the Ga 12 QL-stimulated DNA synthesis in the presence or absence of the COX-2 inhibitors. The pharmacological agents such as aspirin act as nonspeci®c cycloxygenase inhibitors by acetylating COX-1 and COX-2. While COX-1 is readily inhibited at 10 mM concentration of aspirin, COX-2 is inhibited only at a higher concentration (4100 mM) of aspirin. In contrast, the newer COX-2 inhibiting pharmacological agents such as 4-[5-(4-methylphenyl)-3-(tri¯uoro-methyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, celecoxib, commercially known as Celebrex 2 ) are speci®c to COX-2 (Penning et al., 1997) and pharmacologically more potent, requiring as low as 10 mM concentration to inhibit COX-2. Using the dierential sensitivity of COX-2 for aspirin and Celebrex 2 , we investigated whether the inhibition of COX-2 has any eect on Ga 12 QL-stimulated DNA synthesis. Expression of Ga 12 QL increases the rate of DNA synthesis in NIH3T3 cells compared to the control cells (Figure 3 ). The addition of 10 mM aspirin (the inhibitory concentration for COX-1) did not have any eect on either the control or Ga 12 QL-transformed cells. In contrast, 10 mM Celebrex 2 drastically inhibited the DNA synthesis in Ga 12 QL-NIH3T3 transformants as shown in Figure 3 .
These results presented here, for the ®rst time, demonstrate the crucial role of COX-2 in Ga 12 QLmediated mitogenic pathway. Recently, it has been shown that Ga 13 QL stimulates the activation of COX-2 promoter in NIH3T3 cells (Slice et al., 1999) . Hence, it is likely that COX-2 has a similar role in Ga 13 -mediated mitogenic pathway as well. However, Ga 12 diers from Ga 13 by stimulating COX-2 as well as the release of arachidonic acid. It has been considered that the phospholipase-mediated release of arachidonic acid is the rate-limiting step in the biosynthesis of prostaglandins. However, with the identi®cation of COX-2, it has been realized that the synthesis of prostaglandin is regulated at two distinct loci, namely PLA 2 and COX-2 (Reddy and Herschman, 1994) . Through the concerted regulation of PLA 2 and COX-2, Ga 12 ascertains the availability of the substrate (arachidonic acid) as well as the enzyme (COX-2) to maximize the production of prostaglandins and their metablites. Such a co-stimulation of PLA 2 and COX-2 has been proposed to have a causative role in Rasmediated cellular transformation in human non-small cell lung cancer (Heasley et al., 1997) . Perhaps, similar ability of Ga 12 to regulate more than one locus of the eicosanoid pathway contributes signi®cantly to its aggressive growth promoting activity (Figure 4) . The observation that Ga 12 -stimulated DNA-synthesis is inhibited by COX-2 inhibitor has unraveled the presence of a control mechanism hitherto not known in Ga 12 QL-mediated mitogenic pathway. The role of such Ga 12 and COX-2-mediated control mechanisms in other critical pathways regulated by Ga 12 are presently being investigated in the laboratory. It should be noted that the assay procedures described here could also be used to screen and identify the putative COX-2 inhibitors.
